HAEMONETICS CORP — Director's Dealing 2021

May 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2021-05-26

Reporting Person: KROLL MARK W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-26	Common Stock	M	10353	$35.5025	Acquired	30253	Direct
2021-05-26	Common Stock	S	11813	$55.10	Disposed	18440	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-26	Non-qualified Stock Option (Right to Buy)	$35.5025	M	10353	Disposed	2021-07-23	Common Stock (10353)	Direct

Footnotes

F1: The reporting person exercised options that were granted in 2014 and scheduled to expire on July 23, 2021, as reflected in this Form 4.

F2: This number includes unvested restricted stock units previously reported.

F3: Option vests 100% on the first anniversary of the date of grant.